Clinical trial
Open Trial, Not Randomized Study Evaluating the Efficacy and the Tolerance of RD94 in Patients Needing Endodontic Care, Medical Device Class III
NCT01737229 is registered in ClinicalTrials.gov with Ascopharm Groupe Novasco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open Trial, Not Randomized Study Evaluating the Efficacy and the Tolerance of RD94 in Patients Needing Endodontic Care, Medical Device Class III
- Lead sponsor
- Ascopharm Groupe Novasco
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2010
- Completion date
- April 30, 2013
- Enrollment
- 53 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
tooth injury